维普中文期刊产品整合服务
397篇 您的检索式:作者名="ATKINS A"
    题名 作者 年代 出处 被引量
1PD-L1在不同乳腺癌亚型及分期病例中的表达及其肿瘤内异质性:245例原发和40例转移癌的研究显示文摘肿瘤组织中PD—L1表达与多种恶性肿瘤免疫逃逸有关,包括三阴型乳腺癌,通过PD—L1标记有助于选择适合于PD—I/PD—L1抑制剂治疗患者。作者采用组织芯片技术对各种组织学形态的乳腺癌进行PD—L1表达和研究,以探讨其在原发和转移性乳腺癌中的异质性,研究病例包括245例原发性乳腺癌和40例转移性乳腺癌(淋巴结转移及远处转移各20例),瘤细胞PD—L1膜着色细胞≥1%定义为阳性。Dill E A Gru A A Atkins K A.Atkins 王婷 余英豪 2017临床与实验病理学杂志2017,33,10:17
2P16免疫染色可以提高子宫平滑肌肿瘤的组织学分类显示文摘Atkins K A Arronte N Darus C J 黄文斌(摘译) 2008临床与实验病理学杂志2008,24,1:13
3肌萎缩性侧索硬化蛋白激活小胶质细胞NLRP3炎性小体显示文摘小胶质细胞NLRP3炎性小体激活正在成为神经退行性变过程中神经炎症的关键因素。诸如β-淀粉样蛋白和α-突触核蛋白之类的致病性蛋白质聚集体触发小胶质NLRP3激活,从而导致半胱天冬酶-1激活和IL-1β的分泌。在小鼠肌萎缩性侧索硬化症(ALS)的SOD1G93A模型中,半胱天冬酶-1和IL-1β均促进疾病进展,提示小胶质NLRP3在该进程中发挥作用。然而先前的研究表明,SOD1G93A小鼠小胶质细胞不表达NLRP3,SOD1G93A蛋白在小胶质细胞中产生独立于NLRP3的IL-1β。本研究论证了使用Nlrp3-GFP基因敲入小鼠,在SOD1G93A小鼠中小胶质细胞表达NLRP3。本研究显示聚集和可溶性SOD1G93A均可激活小鼠原代小胶质细胞中的炎性小体,导致半胱天冬酶-1和IL-1β裂解,ASC斑点形成以及呈剂量和时间依赖性的IL-1β分泌。重要的是,SOD1G93A无法从缺乏Nlrp3的小胶质细胞或者用特异性NLRP3抑制剂MCC950预处理的小胶质细胞中诱导IL-1β分泌,从而证实NLRP3是介导SOD1诱导的小胶质细胞IL-1β分泌的关键炎症小体复合物。在TDP-43Q331K ALS小鼠模型中也观察到小胶质NLRP3上调,TDP-43野生型和突变蛋白亦可以NLRP3依赖性的方式激活小胶质炎性小体。从机制上讲,本研究确定了活性氧簇和ATP的生成是SOD1G93A介导的NLRP3激活所需的关键事件。总之,本研究的数据表明ALS小胶质细胞表达NLRP3,而病理ALS蛋白激活小胶质NLRP3炎性小体。因此,NLRP3抑制可能是阻止小胶质细胞神经炎症和ALS疾病进展的潜在治疗方法。Vandana Deora John D Lee Eduardo AAlbornoz Luke McAlary Cyril J Jagaraj Avril A B Robertson Julie D Atkin Matthew A Cooper Kate Schroder Justin J Yerbury Richard Gordon Trent MWoodruff 杜一星(编译) 2020神经损伤与功能重建2020,15,9:13
4The reliability of Michaelis constants and maximum velocities estimated by using the integrated Michaelis-Menten equation显示文摘Atkins G L Nimmo I A 1973Biochem J1973,135,4:2
5Complete genomes of two clinical Staphylococcus aureus strains:evidence for the rapid evolution of virulence and drug resistance显示文摘Holden MT Feil EJ Lindsay JA Peacock SJ Day NP Enright MC Foster TJ Moore CE Hurst L Atkin R Barron A Bason N Bentley SD Chillingworth C Chillingworth T Churcher C Clark L Corton C Cronin A Doggett J Dowd L Feltwell T Hance Z Harris B Hauser H Holroyd S Jagels K James KD Lennard N Line A Mayes R Moule S Mungall K Ormond D Quail MA Rabbinowitsch E Rutherford K Sanders M Sharp S Simmonds M Stevens K Whitehead S Barrell BG Spratt BG Parkhill J 2004Proc Natl Acad Sci USA2004,101,26:1
6The Diabetes Control and Complications Trial:the gift that keeps giving显示文摘Kilpatrick E S Rigby A S Atkin S L 0,,10:1
7The valid use of utility in adaptive real-time systems 显示文摘PRASAD D BURNS A ATKINS M 2003Real-Time System2003,25,23:1
8Proteolytic abilities of some Lactic acid bacteria in a model cheese system显示文摘Nana Y Farkye Sabry A Madkor Harriet G Atkins 1995International Dairy Journal1995,5,7:1
9Revision endoscopic sinus surgery: the thomas jefferson university experience显示文摘Moses RL Cornetta A Atkins JP 1998Ear Nose Throat J1998,77,3:1
10Effect of peripherally administered leptin antagonist on whole-body metabolism, and bone microarchitecture and biomechanical properties in mouse显示文摘SOLOMON G ATKINS A SHAHAR R 2014Am J Physiol Endocrinol Metab2014,306,1:1
11Fracture in forming显示文摘Atkins A G 1996Journal of Materials Processing Technology1996,56,:1
12Mechanics of biological materials and structures: nature's lessons for the engineer 显示文摘Jeronimidis G Atkins A G 1995Proc Instn Mech Engnrs1995,209,:1
13Tearing of thin metal sheets显示文摘Atkins A G 1989Structural Failure1989,,:1
14Modelling Metal Cutting Using Modern Ductile Fracture Mechanics: Quantitative Explanations for Some Longstanding Problems 显示文摘Atkins A G 2003International Journal of Mechanical Sciences2003,45,2:1
15Josephson voltage standard by controlling chaos显示文摘Abraham E Atkin I L Wilson A 1999IEEE Trans Appl Supercond1999,9,2:1
16Regenerating functional myocardium: improved perfolrnance after skeletal myoblast transplantation 显示文摘Taylor D A Atkins B Z Hungspreugs P 1998Nat Med1998,4,8:1
17Adalimumab(D2E7) monotherapy in the treatment of patients with severely active rheumatoid arthritis显示文摘van de PUTTE L B A ATKINS C MALAISE M 2002Arthritis Rheum2002,,:1
18Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology 显示文摘Bejon P Berendt A Atkins BL 2010J Antimicrob Chemother2010,65,:1
19Chronic kidney disease in the general population显示文摘White SL Cass A Atkins RC 2005Adv Chronic Kidney Dis2005,12,1:1
20Toughness and Cutting:A New Way of Simultaneously Determining Ductile Fracture Toughness and Strength显示文摘Atkins A G 2005Engineering Fracture Mechanics2005,72,:1
返回顶部 每页显示:
共20页 首页 上一页 第1页 下一页 末页 /20 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费